Top Markets
Coin of the day
Icosavax, Inc. Icosavax, Inc.

Icosavax, Inc.

ICVX
Rang în acțiuni #25854
Icosavax, Inc. operates as a biopharmaceutical firm dedicated to developing... Icosavax, Inc. operates as a biopharmaceutical firm dedicated to developing immunizations against infectious diseases. Leveraging its proprietary virus-like particle (VLP) platform technology, the company primarily focuses its efforts on severe respiratory illnesses. Its developmental portfolio includes several key vaccine candidates: IVX-121, an RSV-targeted vaccine currently undergoing Phase 1/1b clinical trials; IVX-A12, a bivalent candidate designed to target both respiratory syncytial virus (RSV) and human metapneumovirus (hMPV); IVX-241, a candidate specifically designed for hMPV; and IVX-411, a SARS-CoV-2 vaccine based on a receptor binding domain (RBD) sequence antigen, which is also in Phase 1/2 clinical trials. Established in 2017, Icosavax maintains its corporate headquarters in Seattle, Washington.
Preț acțiune
$15.31
Ultima sincronizare: 2024-02-29
Capitalizare de piață
$45.70M
Schimbare (1 zi)
0.00%
Schimbare (1 an)
0.00%
Țară
US
Tranzacționează Icosavax, Inc. (ICVX)

Categorie

Istoricul spliturilor pentru Icosavax, Inc. (ICVX)
Acțiunea Icosavax, Inc. (simbol: ICVX) a trecut printr-un total de 0 splituri.
Cel mai recent split a avut loc pe Aug 20, 2026.
O acțiune ICVX cumpărată înainte de Aug 20, 2026 este echivalentă astăzi cu 0 acțiuni ICVX.
Listă splituri acțiuni
An Split Multiplu Multiplu cumulativ
Nu sunt suficiente date pentru perioada selectată.
Splituri pentru companii similare sau competitori
Companie Număr total de splituri Multiplu cumulativ Țara
1 x2
US
0 -
NL
1 x3
AU
0 -
CH
0 -
US